Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2014 1
2015 2
2016 3
2017 2
2018 2
2019 1
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A, Einsele H, Spencer A, Hajek R, Jurczyszyn A, Lonergan S, Ahmadi T, Liu Y, Wang J, Vieyra D, van Brummelen EMJ, Vanquickelberghe V, Sitthi-Amorn A, de Boer CJ, Carson R, Rodriguez-Otero P, Bladé J, Moreau P; PERSEUS Trial Investigators. Sonneveld P, et al. N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12. N Engl J Med. 2024. PMID: 38084760 Clinical Trial.
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
Tamariz-Amador LE, Rodríguez-Otero P, Jiménez-Ubieto A, Rosiñol L, Oriol A, Ríos R, Sureda A, Blanchard MJ, Hernández MT, Cabañas Perianes V, Jarque I, Bargay J, Gironella M, De Arriba F, Palomera L, Gonzalez-Montes Y, Martí JM, Krsnik I, Arguiñano JM, González ME, Casado LF, González-Rodriguez AP, López-Anglada L, Puig N, Cedena MT, Paiva B, Mateos MV, San-Miguel J, Lahuerta JJ, Bladé J, Trocóniz IF. Tamariz-Amador LE, et al. Among authors: cabanas perianes v. Clin Lymphoma Myeloma Leuk. 2022 Sep;22(9):e844-e852. doi: 10.1016/j.clml.2022.04.024. Epub 2022 May 5. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35688793 Free article.
Skin nodules in multiple myeloma.
Cabañas-Perianes V, Jiménez JM. Cabañas-Perianes V, et al. Blood. 2011 Feb 17;117(7):2088. doi: 10.1182/blood-2010-04-278143. Blood. 2011. PMID: 21433321 Free article. No abstract available.
Circulating aberrant plasma cells allows risk stratification of patients with myeloma.
Periago A, Campillo JA, Mrowiec A, Gimeno L, Montes NR, Martínez-Sánchez MV, Cabañas-Perianes V, García-Garay C, Bolarin JM, Blasco-Mogorrón A, Muro M, Berenguer M, Moraleda JM, García-Alonso AM, Minguela A. Periago A, et al. Among authors: cabanas perianes v. Am J Hematol. 2016 Sep;91(9):E353-E355. doi: 10.1002/ajh.24431. Epub 2016 May 24. Am J Hematol. 2016. PMID: 27220360 Free article. No abstract available.
Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications.
López-Lucas MD, Pachón-Peña G, García-Hernández AM, Parrado A, Sánchez-Salinas D, García-Bernal D, Algueró MDC, Martinez FI, Blanquer M, Cabañas-Perianes V, Molina-Molina M, Asín-Aguilar C, Moraleda JM, Sackstein R. López-Lucas MD, et al. Among authors: cabanas perianes v. Cytotherapy. 2018 Sep;20(9):1110-1123. doi: 10.1016/j.jcyt.2018.07.001. Epub 2018 Aug 29. Cytotherapy. 2018. PMID: 30170815
Effectiveness and safety of rivaroxaban in a cohort of 142 patients with nonvalvular atrial fibrillation treated with rivaroxaban for the prevention of stroke.
Cerezo-Manchado JJ, Navarro-Almenzar B, Elvira-Ruiz G, García-Candel F, Flores-Blanco PJ, Caro-Martínez C, Manzano-Fernández S, García-Iniesta N, Sánchez-García J, Cabañas-Perianes V, Moraleda-Jiménez JM. Cerezo-Manchado JJ, et al. Among authors: cabanas perianes v. Future Cardiol. 2018 May;14(3s):31-37. doi: 10.2217/fca-2018-0024. Future Cardiol. 2018. PMID: 29848091
'Management multiple myeloma during pregnancy: a case report and review'.
Cabañas-Perianes V, Macizo M, Salido E, Blanquer M, Araico F, Melero-Amor A, Garcia-Candel F, Muñoz-Garcia MI, Martinez-Villanueva M, Muñoz-Esparza C, Guzmán-Aroca F, Pérez-López R, Moraleda JM. Cabañas-Perianes V, et al. Hematol Oncol. 2016 Jun;34(2):108-114. doi: 10.1002/hon.2184. Epub 2014 Dec 10. Hematol Oncol. 2016. PMID: 25491088
Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.
Martínez-Sánchez MV, Periago A, Legaz I, Gimeno L, Mrowiec A, Montes-Barqueros NR, Campillo JA, Bolarin JM, Bernardo MV, López-Álvarez MR, González C, García-Garay MC, Muro M, Cabañas-Perianes V, Fuster JL, García-Alonso AM, Moraleda JM, Álvarez-Lopez MR, Minguela A. Martínez-Sánchez MV, et al. Among authors: cabanas perianes v. Oncoimmunology. 2015 Oct 29;5(4):e1093721. doi: 10.1080/2162402X.2015.1093721. eCollection 2016 Apr. Oncoimmunology. 2015. PMID: 27141379 Free PMC article.
14 results